Characterization of HIV type 1 from Romanian children: lack of correlation between V3 loop amino acid sequence and syncytium formation in MT-2 cells. NLM AIDSLINE Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Characterization of HIV type 1 from Romanian children: lack of correlation between V3 loop amino acid sequence and syncytium formation in MT-2 cells.

AIDS Res Hum Retroviruses. 1995 May;11(5):597-603. Unique Identifier : AIDSLINE GENBANK/X77987
Holm-Hansen C; Grothues D; Rustad S; Rosok B; Pascu FR; Asjo B; Centre for International Health, University of Bergen, Norway.


Abstract: The biological properties and amino acid sequences of the third variable domain (V3 loop and flanking regions) of the env region of 34 HIV-1 isolates obtained from Romanian children were analyzed. Unambiguous nucleic acid sequences were obtained from 31 isolates. The derived V3 amino acid sequences were highly homologous (93-100%) and clustered with the HIV-1 subtype F Romanian consensus. Five of the 31 isolates presented a syncytium-inducing phenotype in MT-2 cells and established continuous viral replication in various CD4+ cell lines (rapid/high phenotype). The V3 sequence from one of these isolates showed a slightly lesser degree of homology with the consensus sequence. The presence of positively charged amino acids at positions 306 and 320 has been strongly associated with the ability to induce syncytia in MT-2 cells, whereas negatively or uncharged amino acids at these positions are present in non-syncytium-inducing isolates (slow/low phenotype). There was, however, no correlation between phenotype and amino acid sequence in the five syncytium-inducing isolates; negatively or uncharged amino acids were conserved at positions 306 and 320 for all 31 isolates in sequences obtained from PBMCs. A tendency toward a more positive net charge in the V3 loop of syncytium-inducing isolates was noted. These data confirm the recent observations that HIV-1 isolates from Romania not only cluster in subtype F, but also show a high degree of interpatient homogeneity in the V3 region.(ABSTRACT TRUNCATED AT 250 WORDS)
Keywords: Amino Acid Sequence Base Sequence Cell Line Child Child, Preschool DNA, Viral Giant Cells/VIROLOGY Human HIV Envelope Protein gp120/*GENETICS HIV Seropositivity/BLOOD/*VIROLOGY HIV-1/GENETICS/ISOLATION & PURIF/*PHYSIOLOGY Molecular Sequence Data Peptide Fragments/*GENETICS Phylogeny Romania Sequence Homology, Amino Acid Support, Non-U.S. Gov't JOURNAL ARTICLEKWDaminoacidsequencebasesequencecelllinechildchild,preschooldna,viralgiantcells/virologyhumanhivenvelopeproteingp120/KWDgeneticshivseropositivity/blood/KWDvirologyhiv-1/genetics/isolation&purif/KWDphysiologymolecularsequencedatapeptidefragments/KWDgeneticsphylogenyromaniasequencehomology,aminoacidsupport,non-uKWDsKWDgov'tjournalarticle
960228
M9621033

Copyright © 1996 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .